Although no patients with gastric cancer were included in our study, plasma APE1/Ref-1 has been identified as a valuable marker for the prediction of lymph node metastases in patients with gastric cancer [20]. The gene discussed is APEX1; the disease is metastatic malignant neoplasm in the lymph nodes.